Today's supply chains are under constant pressure. Businesses face a growing number of challenges, such as rising raw ...

Novo Nordisk (NVO) management said it’s not planning any more supply chain acquisitions in the wake of its deal to buy drug manufacturer Catalent (CTLT). Read more here.

As we invest in the future, we will permanently bring our medical supply chains back home. ... (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, ...

In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $81.79 as of Feb 12th. NVO’s trailing and forward P/E were 26.01 and 21.51 ...

Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite disappointing early results. Read more here.

We recently compiled a list of the 20 Biggest Supply Chain Companies to Know and in this article we will take a look at the largest supply chain company in the world. An Analysis of the Supply ...

However, supply chain companies need extra prep work to get the most out of AI. Namely, data will be a factor, as will fear of new technology—the prospect of having it “take your job”—and ...

Supply chain management has been under scrutiny these past few years as global-health, geopolitical and environmental crises have converged to wreak havoc on supply chains. The chip industry, in ...

New research from Accenture finds that companies with the most mature supply chains are 23% more profitable than their peers. These leaders are six times as likely to use AI and generative AI ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading ...